Machine learning-based prognostic model of lactylation-related genes for predicting prognosis and immune infiltration in patients with lung adenocarcinoma

被引:3
作者
Gao, Mingjun [1 ,2 ]
Wang, Mengmeng [1 ,2 ]
Zhou, Siding [4 ]
Hou, Jiaqi [1 ,2 ]
He, Wenbo [3 ]
Shu, Yusheng [2 ,3 ,5 ]
Wang, Xiaolin [2 ,3 ,5 ]
机构
[1] Dalian Med Univ, Dalian 116000, Peoples R China
[2] Dalian Med Univ, Yangzhou Clin Med Coll, Yangzhou 225001, Jiangsu, Peoples R China
[3] Yangzhou Univ, Clin Med Coll, Yangzhou, Peoples R China
[4] Westlake Univ, Affiliated Hangzhou Peoples Hosp 1, Sch Med, Dept Emergency, Hangzhou 310000, Zhejiang, Peoples R China
[5] Yangzhou Univ, Northern Jiangsu Peoples Hosp, Dept Thorac Surg, 98 Nantong West Rd, Yangzhou 225001, Jiangsu, Peoples R China
关键词
Lung adenocarcinoma; Lactylation; Immune; KRT81; PI3K-AKT; CANCER; EXPRESSION; IDENTIFICATION; METABOLISM; LANDSCAPE; HALLMARKS; CELLS;
D O I
10.1186/s12935-024-03592-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundHistone lactylation is a novel epigenetic modification that is involved in a variety of critical biological regulations. However, the role of lactylation-related genes in lung adenocarcinoma has yet to be investigated.MethodsRNA-seq data and clinical information of LUAD were downloaded from TCGA and GEO datasets. Unsupervised consistent cluster analysis was performed to identify differentially expressed genes (DEGs) between the two clusters, and risk prediction models were constructed by Cox regression analysis and LASSO analysis. Kaplan-Meier (KM) survival analysis, ROC curves and nomograms were used to validate the accuracy of the models. We also explored the differences in risk scores in terms of immune cell infiltration, immune cell function, TMB, TIDE, and anticancer drug sensitivity. In addition, single-cell clustering and trajectory analysis were performed to further understand the significance of lactylation-related genes. We further analyzed lactate content and glucose uptake in lung adenocarcinoma cells and tissues. Changes in LUAD cell function after knockdown of lactate dehydrogenase (LDHA) by CCK-8, colony formation and transwell assays. Finally, we analyzed the expression of KRT81 in LUAD tissues and cell lines using qRT-PCR, WB, and IHC. Changes in KRT81 function in LUAD cells were detected by CCK-8, colony formation, wound healing, transwell, and flow cytometry. A nude mouse xenograft model and a KrasLSL-G12D in situ lung adenocarcinoma mouse model were used to elucidate the role of KRT81 in LUAD.ResultsAfter identifying 26 lactylation-associated DEGs, we constructed 10 lactylation-associated lung adenocarcinoma prognostic models with prognostic value for LUAD patients. A high score indicates a poor prognosis. There were significant differences between the high-risk and low-risk groups in the phenotypes of immune cell infiltration rate, immune cell function, gene mutation frequency, and anticancer drug sensitivity. TMB and TIDE scores were higher in high-risk score patients than in low-risk score patients. MS4A1 was predominantly expressed in B-cell clusters and was identified to play a key role in B-cell differentiation. We further found that lactate content was abnormally elevated in lung adenocarcinoma cells and cancer tissues, and glucose uptake by lung adenocarcinoma cells was significantly increased. Down-regulation of LDHA inhibits tumor cell proliferation, migration and invasion. Finally, we verified that the model gene KRT81 is highly expressed in LUAD tissues and cell lines. Knockdown of KRT81 inhibited cell proliferation, migration, and invasion, leading to cell cycle arrest in the G0/G1 phase and increased apoptosis. KRT81 may play a tumorigenic role in LUAD through the EMT and PI3K/AKT pathways. In vivo, KRT81 knockdown inhibited tumor growth.ConclusionWe successfully constructed a new prognostic model for lactylation-related genes. Lactate content and glucose uptake are significantly higher in lung adenocarcinoma cells and cancer tissues. In addition, KRT81 was validated at cellular and animal levels as a possible new target for the treatment of LUAD, and this study provides a new perspective for the individualized treatment of LUAD.
引用
收藏
页数:26
相关论文
共 70 条
[1]   Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage [J].
Aran, Dvir ;
Looney, Agnieszka P. ;
Liu, Leqian ;
Wu, Esther ;
Fong, Valerie ;
Hsu, Austin ;
Chak, Suzanna ;
Naikawadi, Ram P. ;
Wolters, Paul J. ;
Abate, Adam R. ;
Butte, Atul J. ;
Bhattacharya, Mallar .
NATURE IMMUNOLOGY, 2019, 20 (02) :163-+
[2]   Dimensionality reduction for visualizing single-cell data using UMAP [J].
Becht, Etienne ;
McInnes, Leland ;
Healy, John ;
Dutertre, Charles-Antoine ;
Kwok, Immanuel W. H. ;
Ng, Lai Guan ;
Ginhoux, Florent ;
Newell, Evan W. .
NATURE BIOTECHNOLOGY, 2019, 37 (01) :38-+
[3]   Lactate/GPR81 signaling and proton motive force in cancer: Role in angiogenesis, immune escape, nutrition, and Warburg phenomenon [J].
Brown, Timothy P. ;
Ganapathy, Vadivel .
PHARMACOLOGY & THERAPEUTICS, 2020, 206
[4]   IGFBP1 Sustains Cell Survival during Spatially-Confined Migration and Promotes Tumor Metastasis [J].
Cai, Guoqing ;
Qi, Yijun ;
Wei, Ping ;
Gao, Hong ;
Xu, Chenqi ;
Zhao, Yun ;
Qu, Xiujuan ;
Yao, Feng ;
Yang, Weiwei .
ADVANCED SCIENCE, 2023, 10 (21)
[5]   The single-cell transcriptional landscape of mammalian organogenesis [J].
Cao, Junyue ;
Spielmann, Malte ;
Qiu, Xiaojie ;
Huang, Xingfan ;
Ibrahim, Daniel M. ;
Hill, Andrew J. ;
Zhang, Fan ;
Mundlos, Stefan ;
Christiansen, Lena ;
Steemers, Frank J. ;
Trapnell, Cole ;
Shendure, Jay .
NATURE, 2019, 566 (7745) :496-+
[6]   Aberrant methylation of FBN2 in human non-small cell lung cancer [J].
Chen, H ;
Suzuki, M ;
Nakamura, Y ;
Ohira, M ;
Ando, S ;
Iida, T ;
Nakajima, T ;
Nakagawara, A ;
Kimura, H .
LUNG CANCER, 2005, 50 (01) :43-49
[7]   Cancer Statistics in China, 2015 [J].
Chen, Wanqing ;
Zheng, Rongshou ;
Baade, Peter D. ;
Zhang, Siwei ;
Zeng, Hongmei ;
Bray, Freddie ;
Jemal, Ahmedin ;
Yu, Xue Qin ;
He, Jie .
CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (02) :115-132
[8]   Lactylation-Related Gene Signature Effectively Predicts Prognosis and Treatment Responsiveness in Hepatocellular Carcinoma [J].
Cheng, Zhe ;
Huang, Huichao ;
Li, Maoyu ;
Liang, Xujun ;
Tan, Yuying ;
Chen, Yongheng .
PHARMACEUTICALS, 2023, 16 (05)
[9]   Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target [J].
Cook, Peter J. ;
Thomas, Rozario ;
Kannan, Ram ;
de Leon, Esther Sanchez ;
Drilon, Alexander ;
Rosenblum, Marc K. ;
Scaltriti, Maurizio ;
Benezra, Robert ;
Ventura, Andrea .
NATURE COMMUNICATIONS, 2017, 8
[10]   Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase [J].
DuPage, Michel ;
Dooley, Alison L. ;
Jacks, Tyler .
NATURE PROTOCOLS, 2009, 4 (07) :1064-1072